Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. (Q50040421)

23 February 2018

title

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. (English)

1 reference

23 February 2018

triple-negative breast cancer

1 reference

1 reference

Li-Chuan Chan

9

0 references

Taewan Kim

Taewan Kim

10

0 references

Kay-Hooi Khoo

Kay-Hooi Khoo

19

0 references

Gabriel N Hortobagyi

26

Gabriel N Hortobagyi

1 reference

23 February 2018

Mien-Chie Hung

28

Mien-Chie Hung

1 reference

23 February 2018

Ezra M Chung

3

Ezra M Chung

1 reference

23 February 2018

Yen-Liang Liu

14

Yen-Liang Liu

1 reference

23 February 2018

Chao-Kai Chou

13

Chao-Kai Chou

1 reference

23 February 2018

Hirohito Yamaguchi

23

Hirohito Yamaguchi

1 reference

23 February 2018

Shih-Shin Chang

11

Shih-Shin Chang

1 reference

23 February 2018

Weiya Xia

8

Weiya Xia

1 reference

23 February 2018

Heng-Huan Lee

12

Heng-Huan Lee

1 reference

23 February 2018

Jung-Mao Hsu

22

Jung-Mao Hsu

1 reference

23 February 2018

Chu-Wei Kuo

18

Chu-Wei Kuo

1 reference

23 February 2018

Stephen S Yoo

27

Stephen S Yoo

1 reference

23 February 2018

author name string

Chia-Wei Li

1

1 reference

23 February 2018

Seung-Oe Lim

2

1 reference

23 February 2018

Yong-Soo Kim

4

1 reference

23 February 2018

Andrew H Park

5

1 reference

23 February 2018

Jun Yao

6

1 reference

23 February 2018

Jong-Ho Cha

7

1 reference

23 February 2018

Hsin-Chih Yeh

15

1 reference

23 February 2018

Evan P Perillo

16

1 reference

23 February 2018

Andrew K Dunn

17

1 reference

23 February 2018

Jennifer L Hsu

20

1 reference

23 February 2018

Yun Wu

21

1 reference

23 February 2018

Tzu-Hsuan Huang

24

1 reference

23 February 2018

Aysegul A Sahin

25

1 reference

23 February 2018

publication date

1 February 2018

1 reference

23 February 2018

published in

Cancer Cell

1 reference

23 February 2018

volume

33

1 reference

23 February 2018

issue

2

1 reference

23 February 2018

page(s)

187-201.e10

1 reference

23 February 2018

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Deubiquitination and Stabilization of PD-L1 by CSN5.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Antibody drug conjugates: lessons from 20 years of clinical experience

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Precision glycocalyx editing as a strategy for cancer immunotherapy.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Deep and high-resolution three-dimensional tracking of single particles using nonlinear and multiplexed illumination

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Enhanced receptor-clathrin interactions induced by N-glycan-mediated membrane micropatterning

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Large-scale identification of target proteins of a glycosyltransferase isozyme by Lectin-IGOT-LC/MS, an LC/MS-based glycoproteomic approach

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

The blockade of immune checkpoints in cancer immunotherapy

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Mechanisms and principles of N-linked protein glycosylation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Inhibitory B7-family molecules in the tumour microenvironment

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Glycosidase inhibitors: update and perspectives on practical use.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Identification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Genomic cloning and expression of three murine UDP-galactose: beta-N-acetylglucosamine beta1,3-galactosyltransferase genes

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5824730

Scanning N-glycosylation mutagenesis of membrane proteins

29 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29438695

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Definitive evidence that a single N-glycan among three glycans on inducible costimulator is required for proper protein trafficking and ligand binding

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29438695

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CCELL.2018.01.009

1 reference

23 February 2018

0 references

1 reference

23 February 2018